These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38948961)

  • 1. Comparative clinical trials with a novel approach: Utilizing the shiny method for investigational urothelial carcinoma therapies.
    Hara T; Suzuki K; Okada K; Chiba K; Teishima J; Miyake H
    Int J Urol; 2024 Oct; 31(10):1168-1170. PubMed ID: 38948961
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel therapeutic targets in advanced urothelial carcinoma.
    Rouanne M; Loriot Y; Lebret T; Soria JC
    Crit Rev Oncol Hematol; 2016 Feb; 98():106-15. PubMed ID: 26589398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new standard of care for advanced-stage urothelial carcinoma.
    Sidaway P
    Nat Rev Clin Oncol; 2024 May; 21(5):336. PubMed ID: 38509334
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial Comment on Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan.
    Ishihara H; Takagi T
    Int J Urol; 2024 May; 31(5):559-560. PubMed ID: 38366784
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial Comment to Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan.
    Kondo T
    Int J Urol; 2024 May; 31(5):560-561. PubMed ID: 38424666
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Trials Referral Resource. Clinical trials in bladder and urothelial cancers.
    Kaplan RS; Cheson BD; Nelson AP
    Oncology (Williston Park); 1997 Sep; 11(9):1348, 1351. PubMed ID: 9306423
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current developments in urothelial carcinoma].
    Niegisch G; Kramer M
    Urologie; 2024 Oct; 63(10):975-976. PubMed ID: 39373754
    [No Abstract]   [Full Text] [Related]  

  • 8. ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma.
    Powles T; Bellmunt J; Comperat E; De Santis M; Huddart R; Loriot Y; Necchi A; Valderrama BP; Ravaud A; Shariat SF; Szabados B; van der Heijden MS; Gillessen S;
    Ann Oncol; 2024 Jun; 35(6):485-490. PubMed ID: 38490358
    [No Abstract]   [Full Text] [Related]  

  • 9. The landscape of immunotherapy in metastatic urothelial carcinoma.
    Teo MY; Iyer G
    Curr Opin Urol; 2019 Nov; 29(6):643-648. PubMed ID: 31567441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urothelial cancer of the urinary bladder: can lessons learned be applied to the upper urinary tract?
    Krabbe LM; Hutchinson RC; Margulis V
    Minerva Urol Nefrol; 2016 Aug; 68(4):396-408. PubMed ID: 26990295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urothelial cancers: using biology to improve outcomes.
    Pezaro C; Liew MS; Davis ID
    Expert Rev Anticancer Ther; 2012 Jan; 12(1):87-98. PubMed ID: 22149435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highlights from the 2024 ASCO Genitourinary Symposium: focus on urothelial and prostate cancer.
    Strusi A; Pinterpe G; Ciccarese C; Pedone RR; Sarcina M; Sardaro V; Belletto R; Totaro A; Racioppi M; Berardi R; Tortora G; Iacovelli R
    Expert Rev Anticancer Ther; 2024 Aug; 24(8):661-664. PubMed ID: 38932631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic strategies for upper tract urothelial carcinoma.
    Freifeld Y; Krabbe LM; Clinton TN; Woldu SL; Margulis V
    Expert Rev Anticancer Ther; 2018 Aug; 18(8):765-774. PubMed ID: 29848133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new era in the treatment of urothelial carcinoma.
    Faltas B
    Urol Oncol; 2023 Oct; 41(10):395-397. PubMed ID: 37833099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making urothelial carcinomas less immune to immunotherapy.
    Ramos JD; Yu EY
    Urol Oncol; 2016 Dec; 34(12):534-537. PubMed ID: 27836245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial Comment on "Real-world treatment patterns and quality of life among patients with locally advanced or metastatic urothelial carcinoma living in Saudi Arabia, South Korea, Taiwan, and Turkey".
    Giudice GC; Sonpavde GP
    Int J Urol; 2024 Aug; 31(8):943-944. PubMed ID: 38825971
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter to the editor for the article "Molecular urothelial tumor cell subtypes remain stable during metastatic evolution".
    Song Y; Peng Y; Xu T
    World J Urol; 2023 Oct; 41(10):2869-2870. PubMed ID: 37516671
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunotherapy in bladder cancer-quo vadis? Update on current trials and developments].
    Todenhöfer T; Boegemann M
    Urologe A; 2020 Jul; 59(7):810-816. PubMed ID: 32468092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erdafitinib's Road to Approval and Use in Urothelial Carcinoma.
    Hanna K
    Oncology (Williston Park); 2023 Jun; 37(6):260-261. PubMed ID: 37343205
    [No Abstract]   [Full Text] [Related]  

  • 20. New treatments for patients with progressive metastatic urothelial carcinoma.
    Rosenberg JE
    Clin Adv Hematol Oncol; 2021 Mar; 19(3):180-183. PubMed ID: 33739967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.